Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Hold Lower Heterogeneity and Great Promise in Biological Research and Clinical Applications

Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Hold Lower Heterogeneity and Great Promise in Biological Research and Clinical Applications

Mesenchymal stem cells (MSC) isolated from different tissue sources exhibit multiple biological effects and have shown promising therapeutic effects in a broad range of diseases. In order to fulfill their clinical applications in context of precision medicine, however, more detailed molecular charac...

Full description

Bibliographic Details
Main Authors:	Juan Zhang, Mingzhuang Chen, Jinqi Liao, Chongfei Chang, Yuqing Liu, Arshad Ahmed Padhiar, Yan Zhou, Guangqian Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	mesenchymal stem cells (MSCs) induced pluripotent stem cells (iPSCs) iPSC-derived MSCs (iMSCs) heterogeneity functional subpopulations single cell transcriptomics
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.716907/full

Similar Items

Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cells
by: Quanlei Wang, et al.
Published: (2023-01-01)

Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature
by: Lucas-Sebastian Spitzhorn, et al.
Published: (2019-03-01)

Editorial: Targeting Heterogeneity of Mesenchymal Stem Cells
by: Qi Zhang, et al.
Published: (2022-04-01)

The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes
by: Smaranda Dana Buduru, et al.
Published: (2019-01-01)

Muse cells: ushering in a new era of stem cell-based therapy for stroke
by: Han Li, et al.
Published: (2022-08-01)

Replacement of the Trabecular Meshwork Cells—A Way Ahead in IOP Control?
by: Xiaochen Fan, et al.
Published: (2021-09-01)

Rapid and robust derivation of mesenchymal stem cells from human pluripotent stem cells via temporal induction of neuralized ectoderm
by: Wei Jin, et al.
Published: (2022-03-01)

Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022
by: Shabnur Mahmud, et al.
Published: (2022-09-01)

Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells
by: Lidan Luo, et al.
Published: (2020-10-01)

Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier for Regenerative Medicine?
by: Maria Magdalena Barreca, et al.
Published: (2020-05-01)

Pre-Conditioning with IFN-γ and Hypoxia Enhances the Angiogenic Potential of iPSC-Derived MSC Secretome
by: Suya Wang, et al.
Published: (2022-03-01)

Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis
by: Alireza Soltani Khaboushan, et al.
Published: (2024-03-01)

Mesenchymal stem cells in craniofacial reconstruction: a comprehensive review
by: Zizhuo Zheng, et al.
Published: (2024-04-01)

The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases
by: Christina Nikokiraki, et al.
Published: (2022-04-01)

Low-Intensity Pulsed Ultrasound Promotes Osteogenic Potential of iPSC-Derived MSCs but Fails to Simplify the iPSC-EB-MSC Differentiation Process
by: Ziyi Hua, et al.
Published: (2022-05-01)

Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification
by: Ziadoon Al-Akashi, et al.
Published: (2023-02-01)

iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress
by: Masafumi Arakawa, et al.
Published: (2023-09-01)

Protective role of stem cells in POI: Current status and mechanism of action, a review article
by: Somaye Sadeghi, et al.
Published: (2024-01-01)

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01)

Stem Cells for Cancer Therapy: Translating the Uncertainties and Possibilities of Stem Cell Properties into Opportunities for Effective Cancer Therapy
by: Ahmed Faris Aldoghachi, et al.
Published: (2023-01-01)

iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs
by: Hae-Ri Lee, et al.
Published: (2023-01-01)

Cell-Based Therapies in Acute Kidney Injury (AKI)
by: Daniel Patschan, et al.
Published: (2018-05-01)

Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks
by: Gaspare Cucinella, et al.
Published: (2024-01-01)

Introduction to the Special Issue on Stem Cell and Biologic Scaffold Engineering
by: Panagiotis Mallis, et al.
Published: (2019-08-01)

Mesenchymal Stem Cells: The Secret Children’s Weapons against the SARS-CoV-2 Lethal Infection
by: Mario Giosuè Balzanelli, et al.
Published: (2021-02-01)

Producing and Testing Prototype Tissue-Engineered 3D Tri-Leaflet Valved Stents on Biodegradable Poly-ε-Caprolactone Scaffolds
by: Georg Lutter, et al.
Published: (2023-12-01)

Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From F8-Modified iPSCs
by: Liyan Qiu, et al.
Published: (2021-02-01)

Hypoxia as a Driving Force of Pluripotent Stem Cell Reprogramming and Differentiation to Endothelial Cells
by: Paulina Podkalicka, et al.
Published: (2020-11-01)

Stem Cell-Based Therapeutic Strategies in Diabetic Wound Healing
by: Meng-Chien Willie Hsieh, et al.
Published: (2022-08-01)

Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)
by: Nityanand Prakash, et al.
Published: (2023-04-01)

Integration of Transcriptome and MicroRNA Profile Analysis of iMSCs Defines Their Rejuvenated State and Conveys Them into a Novel Resource for Cell Therapy in Osteoarthritis
by: Vasileios Konteles, et al.
Published: (2023-06-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
by: Omer Hatim, et al.
Published: (2023-12-01)

Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
by: Takeshi Tokuyama, et al.
Published: (2021-09-01)

Circulating mesenchymal stem cells and their clinical implications
by: Liangliang Xu, et al.
Published: (2014-01-01)

Single Cell Sequencing of Induced Pluripotent Stem Cell Derived Retinal Ganglion Cells (iPSC-RGC) Reveals Distinct Molecular Signatures and RGC Subtypes
by: Harini V. Gudiseva, et al.
Published: (2021-12-01)

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01)

In vitro Culture of Naïve Human Bone Marrow Mesenchymal Stem Cells: A Stemness Based Approach
by: Bidisha Pal, et al.
Published: (2017-08-01)

Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
by: Na-Hee Lee, et al.
Published: (2020-09-01)

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
by: Arianne Caudal, et al.
Published: (2022-08-01)

OSCI: standardized stem cell ontology representation and use cases for stem cell investigation
by: Yongqun He, et al.
Published: (2019-04-01)